Clinical Trials Sponsored by Bayer/Onyx

Total 2528 results

Bayer

Completed

Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women

Hypertension | Postmenopause
Bayer

Completed

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis

Brain Neoplasms

Japan
Bayer

Completed

Vardenafil in Tinnitus

Tinnitus

Germany
Bayer

Completed

Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries

Wound Healing | Gene Expression | Cell Proliferation

Germany
Bayer

Completed

Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.

Hypertension

Italy, Spain
Bayer

Completed

Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold

Common Cold

United Kingdom
Bayer

Completed

Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis

Chronic Bronchitis

Spain, China, Argentina, Germany, Greece, Portugal, Canada, Netherlands, Australia, Peru, Philippines, Belgium, Switzerland, Chile, Italy, Thailand, Mexico, Lithuania, South Africa, Croatia, France, Colombia, Indonesia, Latvia, Hong Kong, United Kingdom and more
Bayer

Completed

Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980

Hemophilia A

United States
Bayer

Completed

Effect of BAY 43-9006 (Sorafenib) on Cardiovascular Safety Parameters in Cancer Patients

Neoplasms

United States
Bayer

Completed

Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 Inhibitors

Erectile Dysfunction

Spain, Italy, Netherlands, Finland, Germany, France, Sweden
Bayer

Completed

Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)

Uterine Hemorrhage

Ireland, Denmark, Norway
Bayer

Completed

Health Economic Evaluation of Primovist-enhanced Liver MRI

Neoplasm Metastasis | Colorectal Neoplasms

Germany, Spain, Sweden, Switzerland, Italy, Korea, Republic of, Austria, Thailand, Netherlands
Bayer

Terminated

A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small Cell Lung

Belgium, Italy, Spain, Hong Kong, United States, Germany, United Kingdom, Chile, Taiwan, Australia, Canada, Argentina, Puerto Rico, France, Poland, Russian Federation, Sweden, Hungary, Netherlands, Brazil, Korea, Republic of
Bayer

Completed

Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement. (RECORD 4)

Venous Thromboembolism

Poland, United States, India, Denmark, Canada, Sweden, Bulgaria, Israel, Lithuania, Norway, Pakistan, Mexico, Sri Lanka
Bayer

Completed

Investigation of Three Contraceptive Hormone Patches in Regard to Inhibition of Ovulation Following Application Over 3 Treatment Cycles in Healthy, Young Women.

Contraception

Netherlands, Germany
Bayer

Completed

A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia

Pneumonia

Italy
Bayer

Completed

Hepatic Impairment Study

Liver Disease

United States
Bayer

Completed

BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma

Carcinoma, Renal Cell

Russian Federation, France, United States, Germany, Poland, Ukraine, United Kingdom
Bayer

Completed

Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation.

Atrial Fibrillation

Germany
Bayer

Completed

Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement (ODIXaHIP-OD)

Venous Thromboembolism

Italy, Spain, Denmark, Netherlands, Belgium, Austria, Germany, Poland, Sweden, Israel, Norway, United Kingdom, France
Bayer

Completed

Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin

Venous Thromboembolism

Italy, Spain, Poland, United States, Czech Republic, Canada, Denmark, Netherlands, Belgium, Chile, Slovakia, Hungary, Austria, France, Germany, South Africa, Sweden, Turkey, Colombia, Israel, Mexico, Argentina, Norway, Brazil, Lithuania, ... and more
Bayer

Completed

Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function

Contraception

France, Italy, Spain, Germany, United Kingdom
Bayer

Completed

Copanlisib Mass Balance Study

Healthy Volunteers

Netherlands
Bayer

Completed

Special Drug Use Investigation of Glucobay OD

Diabetes Mellitus

Japan
Bayer

Completed

Validation Study for Endometriosis PRO (VALEPRO)

Endometriosis

United States, Germany
Bayer

Completed

ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer

Metastatic Breast Cancer

Spain, Austria, United Kingdom, France, Finland, Poland, Germany, Sweden, Italy, Switzerland
Bayer

Completed

Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration (REVIEW)

Macular Degeneration

Portugal
Bayer

Terminated

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY79-4620 Given Every 2 Weeks to Patients With Advanced Solid Tumors

Neoplasms

Netherlands
Bayer

Completed

Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging

Magnetic Resonance Imaging

Japan
Bayer

Completed

Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.

Vasomotor Symptoms

China
Bayer

Completed

Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist

Fibrosis | Renal Insufficiency | Kidney Failure

United States
Bayer

Completed

A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease

Pelvic Inflammatory Disease

China, Philippines, Thailand, Pakistan, Taiwan, Indonesia, Korea, Republic of
Bayer

Completed

Compare Pharmacokinetic (PK) Profiles of Naproxen Sodium, Diphenhydramine Hydrochloride, and Naproxen Sodium and Diphenhydramine Hydrochloride Combination (Morpheus PK)

Therapeutic Equivalence

United States
Bayer

Completed

Kogenate FS Regulatory Post-Marketing Surveillance (KG0910KR)

Hemophilia A

Korea, Republic of
Bayer

Completed

Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis (Phoenix II)

Dermatitis, Atopic

Germany
Bayer

Completed

Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin

Pharmacokinetics

United States
Bayer

Completed

Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being (COSME)

Contraception

Italy
Bayer

Completed

Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton

Prostate Cancer | Pharmacokinetics | Metastases

United States
Bayer

Completed

Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding

Menorrhagia

Italy
Bayer

Completed

Bioequivalence Study of BAY77-1931 Granule

Hyperphosphatemia

Japan
Bayer

Completed

Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors

Neoplasms

United States
Bayer

Completed

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

Hyperphosphatemia | Dialysis

Japan
Bayer

Completed

Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator (DIGIT)

Raynaud Disease

Germany
Bayer

Completed

Myocardial Perfusion MRI

Magnetic Resonance Imaging | Myocardial Perfusion Imaging

Switzerland, Germany, Austria, Poland
Bayer

Completed

Pharmacokinetics Study Comparing Naproxen Sodium Extended Release and Naprelan

Pharmacokinetics

United States
Bayer

Terminated

Real Life Safety and Efficacy of Vardenafil

Erectile Dysfunction

Taiwan
Bayer

Completed

Pharmacokinetic Study Comparing Aspirin and Aspirin Granules

Pharmacokinetics

United States
Bayer

Completed

Single/Multiple Dose Bioavailability Trial

Healthy

United States
Bayer

Completed

Phase III Study of Sorafenib in Patients With Renal Cell Carcinoma (RCC)

Carcinoma, Renal Cell

China, Taiwan
Bayer

Completed

A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Belgium, Israel, Italy, France, United States

3

Subscribe